Zhi Ge, a 35 year old Singaporean, made his initial appearance in federal court in Boston on Friday after being extradited from Singapore to face securities fraud and money laundering charges, the US Department of Justice said. Ge was arrested in Singapore in 2024, and a Singapore court recently ordered his extradition. He is one of nine people charged over what prosecutors describe as a years long global insider trading network that made tens of millions of dollars trading on confidential information about company finances and merger plans, using tips from investment bankers and other corporate insiders.
Prosecutors say Ge led the scheme from 2016 to 2024 with Samy Khouadja, a former investment banker in France, and Eamma Safi, and that the group paid insiders for tips, traded ahead of deals including AstraZeneca’s 2020 planned $39 billion acquisition of Alexion Pharmaceuticals and Novartis’s 2024 acquisition of MorphoSys for $2.9 billion, and used burner phones and encrypted messaging to conceal the trading. Most of the defendants, including Khouadja, are considered fugitives, while Safi has been in US custody since 2025 and has pleaded not guilty. Ge is due back in court on December 16 for arraignment, and his lawyer said he will plead not guilty.